ENSC
Ensysce Biosciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$3.55M
P/E Ratio
—
EPS
$-3.98
Beta
1.14
52W High
$3.23
52W Low
$0.31
50-Day MA
$0.49
200-Day MA
$1.43
Dividend Yield
—
Profit Margin
-200.80%
Forward P/E
0.76
PEG Ratio
—
About Ensysce Biosciences Inc
Ensysce Biosciences, Inc., a clinical-stage biotechnology company, is dedicated to the development of various prescription drugs. The company is headquartered in La Jolla, California.
Fundamentals
| Revenue (TTM) | $5.07M |
| Gross Profit (TTM) | $-5.31M |
| EBITDA | $-10.23M |
| Operating Margin | -147.80% |
| Return on Equity | -324.90% |
| Return on Assets | -98.10% |
| Revenue/Share (TTM) | $1.98 |
| Book Value | $0.70 |
| Price-to-Book | 1.10 |
| Price-to-Sales (TTM) | 0.70 |
| EV/Revenue | - |
| EV/EBITDA | -0.50 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 44.40% |
| Shares Outstanding | $9.28M |
| Float | $9.27M |
| % Insiders | 0.11% |
| % Institutions | 4.98% |
Analyst Ratings
Consensus ($16.45 target)
Data last updated: 4/29/2026